Research Partners Forums
Research Partners Forums are open dialogues among leaders in academia, business, government, non-profits and the public on subjects related to improving health through research.
COVID-19 treatments exemplify the significance of the public-private sector R&D continuum. While these treatments have not generally received the same level of attention as vaccines, they are critical to our response to the pandemic. This panel discussion explores the range of treatments available; how, when, and in what settings they are administered; and ways to ensure these treatments reach patients in need.
How is COVID-19 affecting progress against cancer and other long-standing health threats? This virtual roundtable discussion explored the impact of the COVID-19 pandemic on public and private sector-fueled medical progress.
This webinar provided a high-level overview of the most promising scientific approaches underway to create vaccines, treat COVID-19 symptoms, cure serious cases, and prevent infection. Panelists discussed how the existing R&D pipeline is being leveraged to address COVID-19 and provided examples of public-private partnerships.
Research is making and continues to make a difference in the lives of individuals across the US and around the globe with rare diseases.
Research is making a difference in the lives of thousands of people with rare diseases, but there is room for more to be done, as the featured guests discussed at Research!America’s reception event, “Rare Diseases: Perspectives on Progress.” The reception, held February 26, 2019, at the Washington Court Hotel, featured a panel of powerful advocates who highlighted the importance of research in improving lives.
Even as dozens of elections across the nation remained undecided or subject to recounts, it was clear that a divided Congress – and a divided nation – would have a significant impact on the future of medical and scientific research. Research!America’s Post-Election Briefing on November 8, at the American Association for the Advancement of Science (AAAS) in Washington, D.C.
“Oral health is often overlooked and undervalued,” according to Research!America’s Director of Policy and Programs Sara Chang who opened a Capitol Hill briefing on the topic October 10, 2018. A panel of experts explored issues related to how oral health is connected to systemic health, the need for more research, and policy issues that can help increase understanding of oral health.
More must be done to ensure robust funding for research that is focused on diseases with disproportionate impact, like migraine. During a panel discussion hosted by Research!America on October 3, 2018 on Capitol Hill, speakers called for more research and workplace accommodations for the 40 million Americans living with migraine.
Stigma remains a top barrier to treatment for mental illness among minority groups, said panelists during a Capitol Hill briefing hosted by Research!America, the Patient-Centered Outcomes Research Institute (PCORI), the National Hispanic Medical Association (NHMA) and the National Medical Association on June 13, 2018.